文献速递哮喘

痰嗜酸性粒细胞增多与重症哮喘磁共振通气异质性

Sputum Eosinophilia and Magnetic Resonance Imaging Ventilation Heterogeneity in Severe Asthma.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01

该研究在27例重症哮喘患者中,以吸入沙丁胺醇前后超极化气体磁共振成像的通气缺陷百分比(VDP)评估平滑肌功能障碍,以痰嗜酸性粒细胞评估气道炎症。结果显示沙丁胺醇改善VDP独立于FEV1变化;痰嗜酸性粒细胞未控制(≥3%)者沙丁胺醇后VDP仍较高,且与痰嗜酸性粒细胞相关。磁共振可区域性地识别炎症与非炎症成分。

要点

  • 沙丁胺醇改善磁共振VDP,反映平滑肌功能障碍,且独立于FEV1改善。
  • 痰嗜酸性粒细胞未控制(≥3%)者沙丁胺醇后VDP持续较高。
  • 沙丁胺醇后VDP与痰嗜酸性粒细胞相关(r=0.63;P=0.005)。

核心结论

  • 在重症哮喘患者中,磁共振可区域性地识别气道疾病的炎症与非炎症成分。
  • 痰嗜酸性粒细胞未控制者沙丁胺醇后通气异质性持续存在,可能是气道炎症的功能性后果。

研究设计与样本

  • 研究纳入27例重症哮喘患者,测量吸入超极化气体磁共振对沙丁胺醇的反应作为平滑肌功能障碍标志。
  • 以痰嗜酸性粒细胞作为气道炎症标志,并量化通气缺陷百分比(VDP)。
  • 同时采集沙丁胺醇前后肺功能与强迫振荡气道阻力测量,按痰嗜酸性粒细胞分组比较。

主要发现

  • 痰嗜酸性粒细胞未控制(≥3%,n=16)者沙丁胺醇后VDP改善(P=0.002)。
  • 痰嗜酸性粒细胞控制(<3%,n=11)者沙丁胺醇后VDP亦改善(P=0.02)。
  • VDP改善独立于FEV1改善,提示平滑肌反应。
  • 痰嗜酸性粒细胞未控制者沙丁胺醇后VDP仍较高(P=0.004)。
  • 沙丁胺醇后VDP与痰嗜酸性粒细胞相关(r=0.63;P=0.005)。

关键数值与推荐

  • 痰嗜酸性粒细胞未控制定义为≥3%(n=16),控制定义为<3%(n=11)。
  • 沙丁胺醇后VDP与痰嗜酸性粒细胞相关系数r=0.63,P=0.005。

临床怎么用

  • 磁共振VDP可用于区分重症哮喘的平滑肌功能障碍与嗜酸性炎症成分。
  • 痰嗜酸性粒细胞未控制者沙丁胺醇后通气异质性持续,提示需关注抗炎治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Inflammation and smooth muscle dysfunction are integral components of severe asthma that contribute to luminal obstruction causing airflow limitation, ventilation heterogeneity, and symptoms. This is important for guiding treatment decisions directed at the inflammatory (e.g., anti-T-helper cell type 2 monoclonal antibodies) and noninflammatory, smooth muscle-mediated (e.g., bronchial thermoplasty) components of severe asthma. OBJECTIVES: To investigate the contribution of eosinophilic bronchitis and smooth muscle dysfunction to magnetic resonance imaging (MRI) ventilation heterogeneity in patients with severe asthma. METHODS: We measured the inhaled hyperpolarized gas MRI response to salbutamol as a marker of smooth muscle dysfunction, and sputum eosinophils as a marker of airway inflammation, and their contributions to ventilation heterogeneity (quantified as the ventilation defect percent [VDP]) in 27 patients with severe asthma. Spirometry and forced oscillation airway resistance measurements were also acquired pre- and postsalbutamol. Patients were dichotomized on the basis of sputum eosinophilia, and pre- and postsalbutamol VDP and physiological measurements were evaluated. MEASUREMENTS AND MAIN RESULTS: MRI VDP improved with salbutamol inhalation in patients in whom sputum eosinophilia was uncontrolled (≥3%, n = 16) (P = 0.002) and in those in whom it was controlled (<3%, n = 11) (P = 0.02), independent of improvements in FEV1, indicating smooth muscle response. In those patients in whom sputum eosinophilia was uncontrolled, greater VDP persisted postsalbutamol (P = 0.004). Postsalbutamol VDP correlated with sputum eosinophils (r = 0.63; P = 0.005). CONCLUSIONS: In patients with severe asthma, MRI regionally identifies the inflammatory and noninflammatory components of airway disease. Ventilation heterogeneity persists postsalbutamol in patients with uncontrolled eosinophilic bronchitis, which may be the functional consequence of airway inflammation.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Svenningsen S, Eddy RL, Lim HF, et al. Sputum Eosinophilia and Magnetic Resonance Imaging Ventilation Heterogeneity in Severe Asthma. Am J Respir Crit Care Med. 2018. PMID: 29313707. doi:10.1164/rccm.201709-1948OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。